Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of oxymatrine in the preparation of anti-osteoclast-mediated bone loss drugs

A technology of oxymatrine and osteoclasts, applied in the field of biomedicine, can solve problems such as late prosthetic loosening

Active Publication Date: 2020-06-23
SHANGHAI FIRST PEOPLES HOSPITAL
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Third, artificial joint replacement surgery has been recognized as an effective means of treating bone and joint diseases and reconstructing joint function. Although the early effect of artificial joint replacement is satisfactory, with the increase in the number of replacement cases and the prolongation of use time, late The problem of prosthetic loosening is becoming more and more prominent
However, in the prior art, there is no report on the application of oxymatrine in the preparation of anti-osteoclast-mediated bone loss drugs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of oxymatrine in the preparation of anti-osteoclast-mediated bone loss drugs
  • Application of oxymatrine in the preparation of anti-osteoclast-mediated bone loss drugs
  • Application of oxymatrine in the preparation of anti-osteoclast-mediated bone loss drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1 Effect of Oxymatrine on Osteolysis Mediated by Osteoclasts and Its Mechanism

[0037] (1) Materials and methods

[0038] 1. Extraction and culture of mouse bone marrow macrophages

[0039] C57 mice aged 2-4 weeks were killed by cervical dislocation, and bilateral femurs and tibias were removed and transferred to a clean bench. Carefully separate muscle and other tissues to fully expose the bone, remove the full-length tibia and femur of the mouse, rinse with PBS 3 times, 3 minutes each time, use sterile scissors to separate the two ends of the long bone, and rinse the bone marrow with a 1ml needle until filled with In the α-MEM medium containing 10% fetal bovine serum, during the flushing process, move the needle up and down to scrape the bone marrow cavity. Use approximately 5ml of medium per bone and discard the bone after flushing is complete. The cell suspension was centrifuged (1000 rpm / 3 min). Discard the supernatant, add culture medium (add 10 ng / ml...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of oxymatrine to preparation of a medicine for resisting osteoclast-mediated bone loss. According to the application, the oxymatrine is innovatively used for treating osteoclast-mediated osteolytic diseases and an inhibition effect of the oxymatrine on osteoclast differentiation is explained for the first time at a cellular level. Meanwhile, a bone and joint unstable model is manufactured by applying anterior cruciate ligament transection; the model has mouse knee joint subchondral bone loss and cells with an osteolysis effect are osteoclasts; an animal experiment result shows that the osteoclast differentiation-mediated subchondral bone loss can be remarkably reduced through intraperitoneal injection of the oxymatrine and the medicine has a remarkable protection effect on mouse joints. Finally, under in vivo conditions, the invention proves that the oxymatrine has no remarkable toxin on visceral organs in a whole body and an ideal new option is provided for treatment of the osteolytic diseases.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to the application of oxymatrine in the preparation of anti-osteoclast mediated bone loss medicine. Background technique [0002] Osteoblasts and osteoclasts are the two most important cells in bone remodeling to maintain bone mass. Osteoclasts are the only cells that absorb bone in the human body. Under physiological conditions, they maintain the metabolic balance of normal bone tissue together with osteoblasts. When the number of osteoclasts increases or the bone resorption function increases, it can cause a variety of common diseases caused by excessive loss of bone mass, including osteoporosis, osteoarthritis, tumor bone metastasis and artificial prosthesis loosening. In my country, more than 200 million people suffer from osteoporosis, and its incidence rate increases rapidly with the aging of our society. The main pathological process leading to osteoporosis is the incre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4375A61P19/08
CPCA61K31/4375
Inventor 姜亚飞马金忠桑伟林朱力波陆海明王聪薛松
Owner SHANGHAI FIRST PEOPLES HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com